Form 8-K - Current report:
SEC Accession No. 0001023024-06-000019
Filing Date
2006-06-12
Accepted
2006-06-09 18:23:34
Documents
2
Period of Report
2006-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K FOR RESULTS OF ANNUAL MEETING annualmeeting8k.htm 8-K 32820
2 BIOSANTE AMENDED AND RESTATED 1998 STOCK PLAN biosantestockplan.htm EX-10.1 100839
  Complete submission text file 0001023024-06-000019.txt   135345
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 06898124
SIC: 2836 Biological Products, (No Diagnostic Substances)